Associate Professor, Medicine, Case Western Reserve University School of Medicine
Rheumatology
Chad L. Deal works in the field of Rheumatology. He went to University of Arkansas for Medical Sciences College of Medicine. University of Arkansas for Medical Sciences College of Medicine is ranked 83 in research and 35 in primary care medicine He received 4 awards: "CMS Meaningful Use Stage 1 Certification", "Fellow", "Fellow (FACR)" and "Top MD". Chad L. Deal, MD is also a published physician. He has 34 paper published. The most recent paper is: Osteoporosis: prevention, diagnosis, and management. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- DXA Utilization Between 2006 and 2012 in Commercially Insured Younger Postmenopausal Women.
- Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis.
- United States adults meeting 2010 american college of rheumatology criteria for treatment and prevention of glucocorticoid-induced osteoporosis.
- Editorial: the regional distribution of rheumatologists: what can we do, what should we do?
- Prevalence of oral glucocorticoid usage in the United States: A general population perspective.
- Recent recommendations on steroid-induced osteoporosis: More targeted, but more complicated.
- A 21-year-old man with Still's Disease with fever, rash, and pancytopenia.
- Absolute fracture risk.
- The United States rheumatology workforce: supply and demand, 2005-2025.
- Successes and failures in improving osteoporosis care after fragility fracture: results of a multiple-site clinical improvement project.
- Risedronate prevents hip fractures, but who should get therapy?
- Raloxifene: a selective estrogen-receptor modulator for postmenopausal osteoporosis - a clinical update on efficacy and safety.
- Can Calcium and vitamin D supplementation adequately treat most patients with osteoporosis?
- Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.
- Clinical update on teriparatide.
- Osteoporosis in elderly: prevention and treatment.
- Using bone densitometry to monitor therapy in treating osteoporosis: pros and cons.
- American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.
- Secondary osteoporosis: are we recognizing it?
- The use of intermittent human parathyroid hormone as a treatment for osteoporosis.
- The role of selective estrogen receptor modulators in the prevention and treatment of osteoporosis.
- Recombinant human PTH 1-34 (Forteo): an anabolic drug for osteoporosis.
- Osteoporosis: prevention, diagnosis, and management.
- Adult hypophosphatasia treated with teriparatide.
- Emerging therapies for osteoporosis.
- Future therapeutic targets in osteoporosis.
- Potential new drug targets for osteoporosis.
- The clinical features of elderly-onset rheumatoid Arthritis. A comparison with younger-onset disease of similar duration.
- Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded...
- Nutraceuticals as therapeutic agents in osteoArthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate.
- Clinical use of teriparatide in the real world: initial insights.
- The Prosorba column for treatment of refractory rheumatoid Arthritis: a randomized, double-blind, sham-controlled trial.
- Factors influencing vertebral bone density after renal transplantation.
Schools
University Of Arkansas For Medical Sciences College Of Medicine Uams University Of Arkansas For Medical Sciences
Boston City Hospital
Boston University Boston City Hospital
Procedures Preformed
- Joint Drainage
- Myofascial Trigger Point Injection
- Non-Spinal Nerve Blocks
- Steroid Injection
- View All
Conditions Treated
- Achilles Tendinitis
- Adhesive Capsulitis
- Antiphospholipid Syndrome (APS)
- Arthritis
- View All
Doctors Specialties
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- CareSource
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- Coventry Health America PPO
- First Health (Coventry Health Care) PPO
- Golden Rule
- GEHA
- Group Health Cooperative
- Harvard Pilgrim Health Care PPO
- Medicare Advantage PFFS
- HealthSmart
- Choice Care PPO
- Kaiser Permanente
- Mail Handlers Benefit Plan (MHBP)
- Medica
- Medicaid
- Medical Mutual of Ohio POS
- Medicare MCR
- Meritain Health
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- MVP Health Care
- NGS CoreSource
- Paramount
- PHP-Physicians Health Plan
- POMCO Group
- Priority Health
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Univera Healthcare
- UPMC Health Plan
- WellCare
- Wells Fargo Insurance
- Worker's Compensation WC
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow
- Fellow (FACR)
- Top MD
Education
-
Boston University Medical Center
-
University of Arkansas for Medical Sciences College of Medicine
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER |
|
1598728446 |
| NPPES Provider LastName |
|
DEAL |
| NPPES Provider FirstName |
|
CHAD |
| NPPES Provider ZIPCode |
|
441950001 |
| NPPES Provider State |
|
OH |
| Specialty Description |
|
Rheumatology |
| Total Claim Count |
|
2096.0 |
| Distinct Opioid Count |
|
3.0 |
| Opioid Claim Count |
|
187.0 |
| Percent Opioid Claims |
|
8.92 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1598728446 |
| Last Name Of The Provider |
DEAL |
| First Name Of The Provider |
CHAD |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.